SEC Comment Letter for Evolus, (EOLS) — Jun 10, 2026
Evolus, Inc.
Date: June 10, 2026 · CIK: 0001570562 · Accession: 0000000000-26-005838
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-296556
Letter
Re: Evolus, Inc. Registration Statement on Form S-3 Filed June 5, 2026 File No. 333-296556 Dear David Moatazedi: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Jason Drory at 202-551-8342 with any questions.
June 10, 2026
David Moatazedi Chief Executive Officer Evolus, Inc. 520 Newport Center Drive, Suite 1200 Newport Beach, CA 92660
Sincerely,
Division of
Corporation Finance
Office of Life
Sciences
cc: Andra Troy
Show Raw Text
<DOCUMENT> <TYPE>TEXT-EXTRACT <SEQUENCE>2 <FILENAME>filename2.txt <TEXT> June 10, 2026 David Moatazedi Chief Executive Officer Evolus, Inc. 520 Newport Center Drive, Suite 1200 Newport Beach, CA 92660 Re: Evolus, Inc. Registration Statement on Form S-3 Filed June 5, 2026 File No. 333-296556 Dear David Moatazedi: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Jason Drory at 202-551-8342 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc: Andra Troy </TEXT> </DOCUMENT>